12:30-14:00 |
AMH AND PERSONALIZED COS
|
| Chairpersons | Bart C.J.M. Fauser, The Netherlands Rene Frydman, France |
| Capsule |
AMH is emerging as a potent tool to predict ovarian response but, can it be used to individualize treatment, to select the mode of treatment in PCOS? The refinement of the assay promises to popularize this test even further |
| 12:30-12:50 |
AMH concentration to establish individual gonadotropins dose |
| 12:50-13:15 | AMH in PCOS patients Narmada Katakam, UK |
| 13:15-13:40 | Role of ovarian response markers in assisted reproduction Dominique De Ziegler, France |
| 13:40-14:00 | Elevated serum thyroid-stimulating hormone is associated with decreased anti-Müllerian hormone in infertile women of reproductive age Keiji Kuroda, Japan |